Free Trial
→ Feds Just Admitted It—They Can Take Your Cash (From Priority Gold) (Ad) Buy ACTU Stock  Free ACTU Stock Alerts

Actuate Therapeutics (ACTU) SEC Filings & 10K Form

Actuate Therapeutics logo
$8.82 -0.22 (-2.38%)
As of 10:24 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Actuate Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/16/2025
11:15 PM		Actuate Therapeutics (Filer)
Form EFFECT
04/16/2025
4:05 PM		Actuate Therapeutics (Filer)
Form 424B3
04/10/2025
4:28 PM		Actuate Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/02/2025
12:41 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:43 PM		Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:44 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
5:23 AM		Actuate Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2025
5:00 AM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:00 PM		Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/24/2024
3:05 PM		Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/20/2024
7:45 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4/A
08/20/2024
7:46 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4/A
08/20/2024
7:46 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4/A
08/19/2024
7:59 PM		Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SC 13D
08/19/2024
4:25 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
8:12 PM		Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:46 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:49 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:51 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:54 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:56 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:44 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 PM		Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:23 PM		Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:23 PM		Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:25 PM		Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:26 PM		Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:27 PM		Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:28 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:29 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:30 PM		Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:14 PM		Actuate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/14/2024
3:37 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
2:11 PM		Actuate Therapeutics (Filer)
Form POS EX
08/13/2024
1:50 PM		Actuate Therapeutics (Filer)
Form 424B4
08/12/2024
11:15 PM		Actuate Therapeutics (Filer)
Form EFFECT
08/12/2024
8:45 PM		Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:46 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:47 PM		Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:48 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
08/12/2024
8:49 PM		Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:57 PM		Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:29 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
12:35 PM		Actuate Therapeutics (Filer)
Form CERT
08/12/2024
10:58 AM		Actuate Therapeutics (Filer)
Form 8-A12B/A
07/23/2024
5:01 AM		Actuate Therapeutics (Filer)
Form S-1/A
07/23/2024
5:01 AM		Actuate Therapeutics (Subject)
Form FWP
07/19/2024
7:01 AM		Actuate Therapeutics (Subject)
Form FWP
07/19/2024
6:58 AM		Actuate Therapeutics (Filer)
Form S-1/A
07/16/2024
1:41 PM		Actuate Therapeutics (Filer)
Form S-1/A
06/21/2024
4:12 PM		Actuate Therapeutics (Subject)
Form FWP
06/21/2024
11:47 AM		Actuate Therapeutics (Filer)
Form S-1/A
06/20/2024
8:40 AM		Actuate Therapeutics (Filer)
Form 8-A12B
06/11/2024
6:01 AM		Actuate Therapeutics (Filer)
Form S-1/A
06/11/2024
6:15 AM		Actuate Therapeutics (Subject)
Form FWP
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ACTU) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Trump purposefully forcing markets to crash…
Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...
Porter & Company | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Amazon Shocker
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...
Stansberry Research | Sponsored